Manufacturing

Manufacturing enables distinguishing between raw material, also called the active pharmaceutical ingredient (API), and the candidate medicinal product.

During the research and discovery phase, only small amounts of the API are produced. However, for non-clinical studies, production of the API should be increased. For clinical studies, the API should be manufactured according to good manufacturing practice (GMP). The active pharmaceutical ingredient should be further formulated to a candidate medicinal product. This could, for instance, be a tablet or a powder that is dissolved for infusion. 

Academic Pharma works together with other companies to change the GMP manufacturing process GMP, and for large scale manufacturing. Within Academic Pharma, there are projects in which the candidate medicinal product is manufactured on a small scale or formulated on a larger scale. Therefore, Academic Pharma focuses on innovations in drug manufacturing, especially for personalised treatment.